MRVI FY 2024 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

MRVIMaravai LifeSciences Holdings, Inc.

$999M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$259M-10.3% YoY

Gross Profit

$108M41.8% margin

Operating Income

-$236M-90.9% margin

Net Income

-$145M-55.9% margin

EPS (Diluted)

$-1.05

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

-$22M

Stock-Based Comp.

$49M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$431M

Stockholders' Equity

$325M

Cash & Equivalents

$322M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$259M	$289M	-10.3%
Gross Profit	$108M	$140M	-22.7%
Operating Income	-$236M	-$32M	-644.5%
Net Income	-$145M	-$119M	-21.7%